Skip to main content
SpringerLink
Log in

NSAIDs and the Elderly

Toxicity and Economic Implications

  • Review Article
  • Pharmacoeconomics
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Despite their propensity to cause toxicity, nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely prescribed for older patients for painful musculoskeletal conditions, many of which are noninflammatory in nature. In some settings, simple analgesia with paracetamol (acetaminophen) or tramadol may be just as effective as NSAIDs.

The benefits of therapy with NSAIDs must be weighed against their potential risks. With the anticipated growth of the elderly population, the economic implications of NSAID use in older patients are staggering. Estimates of the total cost of prescribing NSAIDs to the elderly must include the additional costs of gastroprotective agents, prophylaxis, laboratory monitoring, physician evaluations and interventions for adverse effects.

Misoprostol may be cost effective as primary prophylaxis of NSAID-induced ulcer disease in some elderly patients. NSAIDs may reduce disability and improve quality of life, thereby offsetting their costs. To date, the direct, indirect and intangible cost of NSAIDs and cost offsets have not been systematically evaluated in the elderly. At this juncture, NSAIDs may be used judiciously in older patients, and misoprostol should be considered in high risk patients. Further studies to assess the economics of NSAIDs in the elderly population are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA 1990; 263: 2335–40

    Article  PubMed  CAS  Google Scholar 

  2. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1985; 28: 686–92

    Article  PubMed  CAS  Google Scholar 

  3. Furst DE. Are there significant differences among nonsteroidal anti-inflammatory drugs? Arthritis Rheum 1994; 37: 1–9

    Article  PubMed  CAS  Google Scholar 

  4. Furst DE, Anderson W. Differential effects of diclofenac and aspirin on serum glutamic oxaloacetic transaminase elevations in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1993; 36: 804–10

    Article  PubMed  CAS  Google Scholar 

  5. Cush JJ, Lipsky PE, Postlethwaite AE, et al. Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory therapy in rheumatoid arthritis. Arthritis Rheum 1990; 33: 18–28

    Google Scholar 

  6. Cush JJ, Jasin HE, Johnson R, et al. Relationship between clinical efficacy and laboratory correlates of inflammatory and immunologic activity in rheumatoid arthritis patients treated with nonsteroidal antiinflammatory drugs. Arthritis Rheum 1990; 33: 623–33

    Article  PubMed  CAS  Google Scholar 

  7. Hammerman D. Clinical implications of osteoarthritis and ageing. Ann Rheum Dis 1994; 30: 82–5

    Google Scholar 

  8. Flynn B. Rheumatoid arthritis and osteoarthritis. Current and future therapies. Am Pharm 1994; NS34: 31–42

    PubMed  CAS  Google Scholar 

  9. Murray MD, Brater DC. Nonsteroidal anti-inflammatory drugs. Clin Geriatr Med 1990; 6: 365–441

    PubMed  CAS  Google Scholar 

  10. Dieppe PA, Frankel SJ, Toth B. Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected? Lancet 1993 Feb 6; 341: 353–4

    Article  PubMed  CAS  Google Scholar 

  11. Oddis CV. New perspectives on osteoarthritis. Am J Med 1996; 100 Suppl. 2A: 10S–5S

    Article  PubMed  CAS  Google Scholar 

  12. Bradley JD, Brandt KD, Katz BP, et al. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992; 19: 1950–4

    PubMed  CAS  Google Scholar 

  13. Langmen MJS. Ulcer complications and nonsteroidal anti-inflammatory drugs. Am J Med 1988; 84 Suppl. 2A: 15–9

    Article  Google Scholar 

  14. Welch HG, Albertsen PC, Nease RF, et al. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 1996; 124: 577–84

    PubMed  CAS  Google Scholar 

  15. Cryer B, Feldman M. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory-induced damage. Arch Intern Med 1992; 152: 1145–55

    Article  PubMed  CAS  Google Scholar 

  16. Clinch D, Banerjee AK, Ostick G. Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing 1984; 13: 120–3

    Article  CAS  Google Scholar 

  17. Hochberg MC. Association of nonsteroidal anti-inflammatory drugs with gastrointestinal disease: epidemiologic and economic considerations. J Rheumatol 1992; 19: 63–7

    Google Scholar 

  18. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787–96

    PubMed  CAS  Google Scholar 

  19. Miller DK, Burton FR, Burton MS, et al. Acute upper gastrointestinal bleeding in elderly persons. J Am Geriatr Soc 1991; 39: 409–22

    PubMed  CAS  Google Scholar 

  20. Elashoff JD, Grossman MI. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978. Gastroenterology 1980; 78: 280–5

    PubMed  CAS  Google Scholar 

  21. WHO. World health statistics annual 1985. Geneva: WHO, 1985

    Google Scholar 

  22. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359–63

    PubMed  CAS  Google Scholar 

  23. Freston MS, Freston JW. Peptic ulcers in the elderly: unique features and management. Geriatrics 1990; 45: 39–42

    PubMed  CAS  Google Scholar 

  24. Permutt RP, Cello JP. Duodenal ulcer disease in the hospitalized elderly patient. Dig Dis Sci 1982; 27: 1–6

    Article  PubMed  CAS  Google Scholar 

  25. Simon LS. Toxicities of the nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1992; 4: 301–8

    Article  PubMed  CAS  Google Scholar 

  26. Simon LS, Basch CM, Young DY. Effects of naproxen on renal function in older patients with mild to moderate renal dysfunction. Br J Rheumatol 1992; 31: 563–72

    Article  Google Scholar 

  27. Murray MD, Black PK, Kuzmik DD, et al. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci 1995; 310: 188–7

    Article  PubMed  CAS  Google Scholar 

  28. Kleinknecht D. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995; 15: 228–35

    PubMed  CAS  Google Scholar 

  29. Paulus HE. FDA Arthritis Advisory Committee meeting. Arthritis Rheum 1982; 25: 1124–5

    Article  PubMed  CAS  Google Scholar 

  30. Purcell P, Henry D, Melville G. Diclofenac hepatitis. Gut 1991; 32: 1381–5

    Article  PubMed  CAS  Google Scholar 

  31. Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum 1982; 25: 1013–5

    Article  PubMed  CAS  Google Scholar 

  32. Saag KG, Rubenstein LM, Chrischilles EA, et al. Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly. J Rheumatol 1995; 22: 2142–7

    PubMed  CAS  Google Scholar 

  33. Inman WH. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. BMJ 1977; 1: 1500–5

    Article  PubMed  CAS  Google Scholar 

  34. Bradley JD, Brandt KD, Katz BP, et al. Comparison of an anti-inflammatory dose of ibuprofen, analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87–91

    Article  PubMed  CAS  Google Scholar 

  35. Jones AC, Berman P, Doherty M. Nonsteroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions. BMJ 1992; 31: 45–8

    CAS  Google Scholar 

  36. Bombardier C, Peloso PMJ, Goldsmith CH. Salsalate, a non-acetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. J Rheumatol 1995; 22: 617–24

    PubMed  CAS  Google Scholar 

  37. Blechman WJ, Lechner BL. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylate in rheumatoid arthritis. Rheumatol Rehabil 1979; 18: 119–24

    Article  PubMed  CAS  Google Scholar 

  38. The Multicenter Study Group. Trial of non-acetylated salicylate in RA: does the acetyl group contribute to the antiinflammatory efficacy of salicylic acid in treatment of rheumatoid arthritis? J Rheumatol 1989; 16: 321–7

    Google Scholar 

  39. Townsend RJ. Post-marketing drug research and development. Drug Intell Clin Pharm 1987; 21: 134–6

    PubMed  CAS  Google Scholar 

  40. Bootman JL, Townsend RJ, McGhan WF, et al. Principles of pharmacoeconomics. Cincinnati (OH): Harvey Whitney Books Company, 1991

    Google Scholar 

  41. Accunet Version 6.0. 1996 Mar 11

  42. Greene JM, Winickoff RN. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. Arch Intern Med 1992; 152: 1995–2002

    Article  PubMed  CAS  Google Scholar 

  43. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989; 149: 1019–22

    Article  PubMed  CAS  Google Scholar 

  44. Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med 1988; 84 Suppl. 2A: 20–4

    Article  PubMed  CAS  Google Scholar 

  45. Talley NJ, Evans JM, Fleming KC, et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995; 40: 1345–50

    Article  PubMed  CAS  Google Scholar 

  46. Simon LS, Hind HT, Bittman RM, et al. Risk factors for serious NSAID-induced GI complications: regression analysis of the MUCOSA trial. Fam Med 1996; 28: 202–8

    Google Scholar 

  47. Hogan DB, Campbell NRC, Crutcher R, et al. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. Can Med Assoc J 1994; 151: 315–22

    CAS  Google Scholar 

  48. Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 1993; 119: 257–62

    PubMed  CAS  Google Scholar 

  49. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995; 123: 214–49

    Google Scholar 

  50. Gabriel SE, Jaakkimainen RL, Bombardier C. The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug associated adverse gastrointestinal events. Arthritis Rheum 1993; 36: 447–59

    Article  PubMed  CAS  Google Scholar 

  51. Knill-Jones R, Drummond M, Kohli H, et al. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J 1990; 66: 639–46

    Article  PubMed  CAS  Google Scholar 

  52. Carrin GJ, Torfs KE. Economic evaluation of prophylactic treatment with misoprostol in osteoarthritic patients treated with NSAIDs: the case of Belgium. Rev Epidemiol Sante Publique 1990; 38: 187–99

    PubMed  CAS  Google Scholar 

  53. De Pouvourville G, Bader JP. Analyse économique du traitement préventif par le misoprostol chez l’homme des ulcères gastriques liés aux anti-inflammatoires non stéroïdiens. Gastroenterol Clin Biol 1991; 15: 399–404

    PubMed  Google Scholar 

  54. Edelson JT, Tosteson ANA, Sax P. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. JAMA 1990; 264: 41–7

    Article  PubMed  CAS  Google Scholar 

  55. Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989; 149: 2061–5

    Article  PubMed  CAS  Google Scholar 

  56. Maetzel A, Ferraz MB, Bombardier C. A new examination of the cost-effectiveness of misoprostol in preventing serious gastrointestinal bleeding due to NSAIDs [abstract]. Arthritis Rheum 1995; 38 Suppl.: S206

    Google Scholar 

  57. Gabriel SE, Campion ME, O’Fallon WM. A cost utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 1994; 37: 333–41

    Article  PubMed  CAS  Google Scholar 

  58. De Pouvourville G. Pharmacoeconomics of the prevention of NSAID-induced ulcers and their complications. N Standards Arthritis Care 1996; 5: 7–10

    Google Scholar 

  59. Centers for Disease Control and Prevention. Arthritis prevalence and activity limitations: United States. MMWR Morb Mortal Wkly Rep 1990; 43: 433–8

    Google Scholar 

  60. French MT, Mauskopf JA. A quality-of-life method for estimating the value of avoided morbidity. Am J Public Health 1992; 82: 1553–5

    Article  PubMed  CAS  Google Scholar 

  61. Devellis BM. Depression in rheumatological diseases. Baillieres Clin Rheumatol 1993; 7: 241–57

    Article  PubMed  CAS  Google Scholar 

  62. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995; 122: 61–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

    Andrée C. Phillips, Richard P. Polisson &  Lee S. Simon

  2. Medical Service (Arthritis Unit), Massachusetts General Hospital, Boston, Massachusetts, USA

    Andrée C. Phillips, Richard P. Polisson &  Lee S. Simon

  3. The Beth Israel Deaconess Medical Center, One Deaconess Road, Boston, MA, 02215, USA

    Lee S. Simon

Authors
  1. Andrée C. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard P. Polisson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lee S. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lee S. Simon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phillips, A.C., Polisson, R.P. & Simon, L.S. NSAIDs and the Elderly. Drugs & Aging 10, 119–130 (1997). https://doi.org/10.2165/00002512-199710020-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199710020-00005

Keywords

Search

Navigation